Potential Gene Therapy May Improve Survival in MNGIE Patients, Mouse Study Suggests
News
A gene therapy designed to correct the underlying defect that causes mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) could potentially improve survival in patients with the disease, a mouse study suggests. The ... Read more